PDCD1 and cancer: For example, Colony-Stimulating Factor Receptor 1 (CSF1R) inhibitor was able to overcome PD-1/PD-L1 chemotherapy resistance in some cancers (Magkouta et al., 2021; Omstead et al., 2022).